Results 261 to 270 of about 3,691,927 (315)

LASP1 in Tumor and Tumor Microenvironment

Current Molecular Medicine, 2018
The growing evidence shows that LIM and SH3 Domain Protein 1 (LASP1) is a multi-functional protein that plays important role in forming cytoskeleton and prognostic marker in different cancers. LASP1 expression is correlated with the grade, size, and the metastasis of tumor in clinical samples.
Z, Hu, X, Wang, Y, Cui, C, Li, S, Wang
openaire   +2 more sources

Tumor-to-tumor metastasis

Anti-Cancer Drugs, 2013
Tumor-to-tumor metastasis is a rare phenomenon, with around 150 cases being reported in the literature. Breast cancer is the second most commonly reported donor tumor after lung cancer, but thymic epithelial tumors have never been reported as recipient tumors. Furthermore, the thymus is rarely affected by metastases.
Moretto R, Cella CA, Raimondo L, Formisano L, Nappi L, Rescigno P, Buonerba C, Calabrese F, Ottaviano M, Di Lorenzo G, Matano E, Damiano V, Palmieri G.   +12 more
openaire   +4 more sources

Tumor-to-Tumor Metastasis: Extracranial Tumor Metastatic to Intracranial Tumors

2011
Tumor-to-tumor metastasis (TTM) is a relatively rare but well-documented phenomenon. When malignant tumor metastasizes to an intracranial tumor, meningiomas are most often the recipient; and breast or lung carcinoma the most common donor (primary tumor). The diagnosis of TTM can be made only by histopathological examination.
Jian-Qiang Lu, Arthur W. Clark
openaire   +1 more source

Brain Tumors

2011
For most cancers, PET is essentially a diagnostic tool. For brain tumors, PET has got its main contribution at the level of the therapeutic management. Indeed, specific reasons render the therapeutic management of brain tumors, especially gliomas, a real challenge. Although some gliomas may appear well-delineated on conventional neuroimaging such as CT
Goldman, Serge, Pirotte, Benoît
openaire   +3 more sources